This topic contains a solution. Click here to go to the answer

Author Question: Public administrators have little or no advantage over many others in American society when it comes ... (Read 26 times)

Lisaclaire

  • Hero Member
  • *****
  • Posts: 569
Public administrators have little or no advantage over many others in American society when it comes to seeing and understanding such concerns as poverty, drug addition, and homelessness.
 
  a. True
  b. False

Question 2

Which of these is not a reason that OPEC's initial strength was limited?
 
  A. Near monopoly control of oil companies
   B. U.S. energy self-sufficiency
   C. Production exceeded demand
   D. Saudi Arabia refused to join at first



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

babybsemail

  • Sr. Member
  • ****
  • Posts: 304
Answer to Question 1

b

Answer to Question 2

D




Lisaclaire

  • Member
  • Posts: 569
Reply 2 on: Jul 12, 2018
Wow, this really help


xiazhe

  • Member
  • Posts: 331
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Only 12 hours after an egg cell is fertilized by a sperm cell, the egg cell starts to divide. As it continues to divide, it moves along the fallopian tube toward the uterus at about 1 inch per day.

Did you know?

More than 20 million Americans cite use of marijuana within the past 30 days, according to the National Survey on Drug Use and Health (NSDUH). More than 8 million admit to using it almost every day.

Did you know?

Immunoglobulin injections may give short-term protection against, or reduce severity of certain diseases. They help people who have an inherited problem making their own antibodies, or those who are having certain types of cancer treatments.

Did you know?

Colchicine is a highly poisonous alkaloid originally extracted from a type of saffron plant that is used mainly to treat gout.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library